Non-lethal weapons company Byrna (NASDAQ:BYRN) will be reporting earnings tomorrow before market open. Here’s what to expect.
Byrna met analysts’ revenue expectations last quarter, reporting revenues of $27.98 million, up 78.9% year on year. It was an exceptional quarter for the company, with a solid beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.
Is Byrna a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Byrna’s revenue to grow 57% year on year to $26.15 million, slowing from the 98% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.02 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Byrna has missed Wall Street’s revenue estimates five times over the last two years.
Looking at Byrna’s peers in the aerospace and defense segment, only AAR has reported results so far. It missed analysts’ revenue estimates by 2.8%, delivering year-on-year sales growth of 19.5%. The stock was down 16.3% on the results.
Read our full analysis of AAR’s earnings results here.
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. We prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
